GKOS
Glaukos Corporation
NYSE · usd
Glaukos Corporation (GKOS) trades at $178.27 (-0.34%) as of 4:10:04 PM EDT on Oct 26, 2026, +15.44% over the past month. Market cap is $10.55B, with 4.1 days to cover in short interest.
Stock performance
How Glaukos Corporation (GKOS) stock has performed from one day to one year, with its 52-week range.
- 1D
- -0.34%
- 1W
- +6.77%
- 1M
- +15.44%
- YTD
- +57.89%
- 1Y
- +135.56%
- 52-wk range
- $73.16 – $191.62
Key statistics
Today's trading snapshot for GKOS: day range, open, previous close, volume and market cap.
- Day range
- $176.43 – $181.65
- Open
- $177.35
- Prev close
- $178.88
- Volume
- 1.06M
- Market cap
- $10.55B
- Shares out
- 58.98M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Glaukos Corporation: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 17.22
- P/B
- 15.46
- P/FCF
- —
- ROE
- -27.6%
- ROA
- -20.4%
- Debt/Equity
- 0.10
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Glaukos Corporation has disclosed to the SEC on Form 8-K.
- Investor presentationAug 3, 2026
Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com.
- Annual meeting resultsJun 3, 2026
The annual meeting of stockholders (the "Annual Meeting") of Glaukos Corporation (the "Company") was held on May 28, 2026. At the Annual Meeting, the Company's stockholders voted on three proposals... The final voting results for each matter submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1. The election of two Class II directors... Proposal 2. The non-binding advisory vote regarding approval of the compensation of the Company's named executive officers... Proposal 3. The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.
- Investor presentationMay 4, 2026
Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com.
- Investor presentationMar 2, 2026
Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com.
- Investor presentationJan 13, 2026
The Company intends to present the materials attached as Exhibit 99.2 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com.
GKOS short interest
How heavily GKOS is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 4.1
- Short interest
- 3.85M
- Avg volume
- 944.4K
As of · reported to FINRA twice monthly.
GKOS news
The latest news and headlines about Glaukos Corporation (GKOS).
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?positiveZacks Investment Research· Oct 23, 2026
- DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?neutralZacks Investment Research· Oct 22, 2026
- BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?positiveZacks Investment Research· Oct 22, 2026
- Forge’s Fierce Life Sciences Announces 2026 Fierce Innovation Awards Finalists and Unveils the Fierce Vanguard GalapositiveGlobeNewswire Inc.· Oct 19, 2026
- Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally?positiveZacks Investment Research· Oct 14, 2026
Frequently asked questions
What is the Glaukos Corporation (GKOS) stock price today?
Glaukos Corporation (GKOS) is trading at $178.27 (-0.34% on the day) as of 4:10:04 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Glaukos Corporation?
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases.
What is the short interest in GKOS?
As of Sep 30, 2026, GKOS has 3.85M shares short and 4.1 days to cover.
What exchange is GKOS listed on?
Glaukos Corporation (GKOS) trades on NYSE in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of GKOS with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a GKOS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.